Structure Therapeutics (GPCR) EBITDA (2022 - 2026)

Quarterly EBITDA fell 68.79% to -$79.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$173.3 million through Mar 2026, down 21.72% year-over-year, with the annual reading at -$141.1 million for FY2025, 15.5% down from the prior year.

Structure Therapeutics' EBITDA history spans 5 years, with the latest figure at -$79.2 million for Q1 2026.

  • EBITDA came in at -$79.2 million for Q1 2026, down from $33.2 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $33.2 million in Q4 2025 to a low of -$79.2 million in Q1 2026.
  • The 5-year median for EBITDA is -$23.8 million (2023), against an average of -$28.4 million.
  • The largest YoY upside for EBITDA was 186.54% in 2025 against a maximum downside of 135.0% in 2025.
  • Structure Therapeutics' EBITDA stood at -$11.8 million in 2022, then crashed by 99.76% to -$23.7 million in 2023, then tumbled by 62.23% to -$38.4 million in 2024, then surged by 186.54% to $33.2 million in 2025, then crashed by 338.37% to -$79.2 million in 2026.
  • Per Business Quant, the three most recent readings for GPCR's EBITDA are -$79.2 million (Q1 2026), $33.2 million (Q4 2025), and -$65.2 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - -13.63 Mn
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn -19.70 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - -14.44 Mn
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 1.14 Bn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 661.60 Mn
8 Evaxion A 65.12 Bn 65.10 Bn - -3.82 Mn
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 201.19 Mn
10 Structure Therapeutics 8.43 Bn 8.43 Bn - -79.22 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -79.22 Mn
Dec 31, 2025 33.23 Mn
Sep 30, 2025 -65.25 Mn
Jun 30, 2025 -62.11 Mn
Mar 31, 2025 -46.93 Mn
Dec 31, 2024 -38.40 Mn
Sep 30, 2024 -30.65 Mn
Jun 30, 2024 -26.43 Mn
Mar 31, 2024 -26.65 Mn
Dec 31, 2023 -23.67 Mn
Sep 30, 2023 -23.78 Mn
Jun 30, 2023 -23.82 Mn
Mar 31, 2023 -17.72 Mn
Dec 31, 2022 -11.85 Mn
Sep 30, 2022 -12.47 Mn
Jun 30, 2022 -14.00 Mn
Mar 31, 2022 -13.12 Mn